CMC Biologics Company Profile

12:05 EDT 22nd May 2015 | BioPortfolio

CMC Biologics (www.cmcbio.com) is a leading contract development and manufacturing organization that provides fully integrated biopharmaceutical development and manufacturing services to clients around the world, from its facilities in Europe and the USA. The company specializes in custom services for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials and in-market production. CMC Biologics' wide range of integrated services includes cell line development using its proprietary CHEF1® system, process development and comprehensive analytical testing. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both stirred tank and perfusion production processes. CMC Biologics is located in Copenhagen, Denmark, and Bothell, Washington, near Seattle.


News Articles [408 Associated News Articles listed on BioPortfolio]

WuXi PharmaTech Making Good on Biologics Investments

With the end of 2014 almost here, WuXi PharmaTech sent a Christmas greeting that highlights the China CRO/CMO's accomplishments in biologics, including having built the largest biologics development t...

DSM Biologics: Karen King on New Technology and Reducing the Cost of Medicines

In this episode of PharmaTelevision News Review, Fintan Walton talks with Karen King, President and Business Unit Director of DSM Biologics. Filmed at BioChicago 2010 in Chicago, USA, they discuss: ...

WuXi Biologics to build world's largest biologics facility

Biospectrum Upon completion the new facility will further expand WuXi's already extensive biologics manufacturing capab...

CMC Biologics schließt kommerziellen Liefervertrag mit Emergent BioSolutions für das von der FDA zugelassene IXINITY® ab

- Das Produkt wird im Werk von CMC Biologics in Seattle, Washington, hergestellt - Seattle (ots/PRNewswire) - CMC Biologics, Inc. [http://www.cmcbiologics.com/], ein weltweiter Vertragshersteller (...

Qu Biologics to work with University of Rochester

Vancouver, BC – Qu Biologics Inc. reports it has initiated a research collaboration with the laboratory of Dr. Michael R. Elliott of the University of Rochester School of Medicine and Dentistry....

Biologics Are Revolutionizing Care for Some Diseases, But They Are Very Costly

(Washington Post) – Biologics are different from chemically derived drugs such as antibiotics: They are made from living organisms and require special handling in a controlled temperature while ...

New anorexia treatment in the works? Cambridge startup gets $28.3M to develop biologics that restore homeostasis

Biologics are typically used as therapeutics, but a Cambridge startup is using precise protein chemistry to move the field a little closer to the nutraceutical space. Pronutria‘s biologics are ...

CORRECTED-BRIEF-Astrazeneca to invest $285 mln in biologics facility in Sweden

* To invest in new biologics manufacturing facility in Södertälje, Sweden, to support accelerating biologics portfolio

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Standardized cat pelt [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT PELT AP ACETONE PRECIPITATED

Standardized cat hair [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT HAIR AP Acetone Precipitated

Cinryze [ViroPharma Biologics]

These highlights do not include all the information needed to use CINRYZE™ safely and effectively. See full prescribing information for CINRYZE.CINRYZE™ (C1 Esterase Inhibitor [Human]) For Intrave...

PubMed Articles [78 Associated PubMed Articles listed on BioPortfolio]

Patch Test Results in Psoriasis Patients on Biologics.

The objective of this study was to determine the prevalence of positive patch tests in patients with psoriasis receiving biologics and whether these results differ from those of patients with psoriasi...

The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review.

Economic evaluations provide information to aid the optimal utilization of limited healthcare resources. Costs of biologics for Rheumatoid arthritis (RA) are remarkably high, which makes these agents ...

Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States.

Aaron Kesselheim and colleagues examine potential strategies to promote greater prescribing of generic drugs and follow-on biologics.

Progress and Hurdles for Follow-on Biologics.

In March 2015, the Food and Drug Administration (FDA) approved filgrastim-sndz (Zarxio), Sandoz's version of the leukocyte growth factor Neupogen, an Amgen drug indicated for conditions including neut...

Biologics in Spine Arthrodesis.

Cervical and lumbar spine arthrodesis is performed in the treatment of spine trauma, tumors, and degenerative disorders with an estimated 200,000 fusion procedures performed in the United States annua...

Clinical Trials [29 Associated Clinical Trials listed on BioPortfolio]

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

This study involves review and analysis of disease activity in patients with rheumatoid arthritis who where treated with either conventional DMARDs (Disease Modifying Antirheumatic Drugs) ...

Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)

Biologics are routinely used for the treatment of rheumatoid arthritis (RA). Adalimumab is a human monoclonal antibody that inhibit the Tumor Necrosis Factor alpha (TNF-alpha). Identificat...

Companies [198 Associated Companies listed on BioPortfolio]

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

Precision Biologics, Inc.

Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic ...

GT Biologics

GT Biologics is focused on the research and development of Live Biotherapeutics (LBPs) for the treatment of autoimmune diseases. GT Biologics aim to deliver a new class of medicine based on the po...

Permeon Biologics

Permeon Biologics is pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. Leveraging its novel Intraphilinâ...

CMC Biologics

CMC Biologics (www.cmcbio.com) is a leading contract development and manufacturing organization that provides fully integrated biopharmaceutical development and manufacturing services to clients aroun...

More Information about "CMC Biologics" on BioPortfolio

We have published hundreds of CMC Biologics news stories on BioPortfolio along with dozens of CMC Biologics Clinical Trials and PubMed Articles about CMC Biologics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CMC Biologics Companies in our database. You can also find out about relevant CMC Biologics Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record